$6100 | Single User
$10500 | Site License
$17000 | Enterprise License

Varicose Veins Forecast in 15 Major Markets 2015-2025
[Lowest Price Guaranteed: $6,100]

Published by Black Swan Analysis: 01 Nov 2015 | 81328 | In Stock
Related Topics: Delivery , Hypertension , Obesity

Introduction

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Varicose Veins in 15 Major Markets

There are three different types of varicose veins: trunk, reticular and telangiectasia. This indication report details the prevalence of trunk varicose veins. Trunk varicose veins are near to the surface of the skin and are thick and knobbly in appearance. The vein becomes incompetent and varicosities develop when a section with poorly functioning valves allows back-flow into the vein causing build-up of blood and distension of the vein.

This report provides the current prevalent population for varicose veins across 15 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Turkey, Mexico, Argentina, Poland, Russia and China) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of segments affected, severity and patterns of varicose veins, to name a few. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of varicose veins have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for varicose veins include:

• Deep vein thrombosis

• Obesity

• Hypertension

• Phlebitis

• Chronic venous insufficiency

• Venous ulcer

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

• Able to quantify patient populations in global varicose veins’ market to target the development of future products, pricing strategies and launch plans.

• Gain further insight into the prevalence of the subdivided types of varicose veins and identify patient segments with high potential.

• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.

• Provide a level of understanding on the impact from specific co-morbid conditions on varicose veins’ prevalent population.

• Identify sub-populations within varicose veins which require treatment.

• Gain an understanding of the specific markets that have the largest number of varicose veins patients.

Table of Contents
for Varicose Veins Forecast in 15 Major Markets 2015-2025

  • Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Varicose Veins in 15 Major Markets

    There are three different types of varicose veins: trunk, reticular and telangiectasia. This indication report details the prevalence of trunk varicose veins. Trunk varicose veins are near to the surface of the skin and are thick and knobbly in appearance. The vein becomes incompetent and varicosities develop when a section with poorly functioning valves allows back-flow into the vein causing build-up of blood and distension of the vein.

    This report provides the current prevalent population for varicose veins across 15 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Turkey, Mexico, Argentina, Poland, Russia and China) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of segments affected, severity and patterns of varicose veins, to name a few. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

    Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of varicose veins have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

    Main symptoms and co-morbidities for varicose veins include:

    • Deep vein thrombosis

    • Obesity

    • Hypertension

    • Phlebitis

    • Chronic venous insufficiency

    • Venous ulcer

    This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

    Reason to buy

    • Able to quantify patient populations in global varicose veins’ market to target the development of future products, pricing strategies and launch plans.

    • Gain further insight into the prevalence of the subdivided types of varicose veins and identify patient segments with high potential.

    • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.

    • Provide a level of understanding on the impact from specific co-morbid conditions on varicose veins’ prevalent population.

    • Identify sub-populations within varicose veins which require treatment.

    • Gain an understanding of the specific markets that have the largest number of varicose veins patients.

List Of Tables
in Varicose Veins Forecast in 15 Major Markets 2015-2025

Table of Contents

• List of Tables and Figures

• Introduction

• Cause of the Disease

• Risk Factors and Prevention

• Diagnosis of the Disease

• Variation by Geography/ Ethnicity

• Disease Prognosis and Clinical Course

• Key Co-Morbid Conditions / Features associated with the Disease

• Methodology for Quantification of Patient Numbers

• Top-Line Prevalence for Varicose Veins

• Features of Varicose Veins Patients

• Associated Co-morbid Conditions of Varicose Veins

o Reflux-related Conditions

o Skin-related Conditions

• Abbreviations used in the Report

• Other Black Swan Analysis Publications

• Black Swan Analysis Online Patient-Based Databases

• Patient-Based Offering

• Online Pricing Data and Platforms

• References

• Appendix


List of Tables

• CEAP classification for varicose veins

• Prevalence of varicose veins, total (000s)

• Prevalence of varicose veins, males (000s)

• Prevalence of varicose veins, females (000s)

• Patterns of varicose veins in patients, total (000s)

• Number of segments affected in patients with varicose veins, total (000s)

• Severity of varicose veins by CEAP class in patients with varicose veins, total (000s)

• Functional disease status of patients with varicose veins, total (000s)

• Prevalence of GSV reflux in patients with varicose veins, total (000s)

• Prevalence of saphenofemoral junction reflux in patients with varicose veins, total (000s)

• Prevalence of saphenopopliteal junction reflux in patients with varicose veins, total (000s)

• Prevalence of oedema in patients with varicose veins, total (000s)

• Prevalence of skin changes in patients with varicose veins, total (000s)

• Abbreviations and Acronyms used in the report

• USA prevalence of varicose veins by 5-yr age cohort, males (000s)

• USA prevalence of varicose veins by 5-yr age cohort, females (000s)

• France prevalence of varicose veins by 5-yr age cohort, males (000s)

• France prevalence of varicose veins by 5-yr age cohort, females (000s)

• Germany prevalence of varicose veins by 5-yr age cohort, males (000s)

• Germany prevalence of varicose veins by 5-yr age cohort, females (000s)

• Italy prevalence of varicose veins by 5-yr age cohort, males (000s)

• Italy prevalence of varicose veins by 5-yr age cohort, females (000s)

• Spain prevalence of varicose veins by 5-yr age cohort, males (000s)

• Spain prevalence of varicose veins by 5-yr age cohort, females (000s)

• United Kingdom prevalence of varicose veins by 5-yr age cohort, males (000s)

• United Kingdom prevalence of varicose veins by 5-yr age cohort, females (000s)

• Brazil prevalence of varicose veins by 5-yr age cohort, males (000s)

• Brazil prevalence of varicose veins by 5-yr age cohort, females (000s)

• Japan prevalence of varicose veins by 5-yr age cohort, males (000s)

• Japan prevalence of varicose veins by 5-yr age cohort, females (000s)

• India prevalence of varicose veins by 5-yr age cohort, males (000s)

• India prevalence of varicose veins by 5-yr age cohort, females (000s)

• Turkey prevalence of varicose veins by 5-yr age cohort, males (000s)

• Turkey prevalence of varicose veins by 5-yr age cohort, females (000s)

• Mexico prevalence of varicose veins by 5-yr age cohort, males (000s)

• Mexico prevalence of varicose veins by 5-yr age cohort, females (000s)

• Poland prevalence of varicose veins by 5-yr age cohort, males (000s)

• Poland prevalence of varicose veins by 5-yr age cohort, females (000s)

• Argentina prevalence of varicose veins by 5-yr age cohort, males (000s)

• Argentina prevalence of varicose veins by 5-yr age cohort, females (000s)

• Russia prevalence of varicose veins by 5-yr age cohort, males (000s)

• Russia prevalence of varicose veins by 5-yr age cohort, females (000s)

• China prevalence of varicose veins by 5-yr age cohort, males (000s)

• China prevalence of varicose veins by 5-yr age cohort, females (000s)

List Of Figures, Charts and Diagrams
in Varicose Veins Forecast in 15 Major Markets 2015-2025

See List of Tables for the Figures

Additional Details

Publisher

Black Swan Analysis

Publisher Information

Black Swan Analysis, founded in 2007, is a unique analysis practice that provides robust valuations and commercialisation plans to optimise products in the healthcare industry. We know what it takes to succeed in this industry -we’ve seen what works and what doesn’t and we are committed to bringing insight and high quality solutions to our clients. In doing so we help them meet the many challenges of today’s complex healthcare marketplace.



The Black Swan team has a unique skill set: the ability to develop dynamic market forecasts and interactive patient flow models using a wide range of data including complex pathological and epidemiological information. As pharmaceutical and healthcare companies are challenged to deliver more specific targets that align with unmet medical needs. These modelling approaches are more commercially focused to meet the requirements of a changing healthcare environment.



We have the capability to provide an immediate and ‘hands-on’ approach with every client and where the right internal expertise is leveraged we can help find your optimal solution. Using our bespoke methodologies and frameworks we seek to assess the most challenging valuations.



The valuation outputs we generate can be easily integrated with any in-house existing financial systems, presentation styles or platforms that may be currently operational. This ensures a faster uptake within the business, enabling resources to be re-directed towards implementing the outputs and leveraging new information.



Our philosophy at Black Swan is to create the right environment using inclusive dialogues and collaboration that enable us to generate outputs that make business decisions clear. Our goal is to provide an unparalleled level of satisfaction and quality for our clients.

Reference

81328 | VARI0011115

Number of Pages

60

Report Format

PDF

Black Swan Analysis Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Varicose Veins - Market Insights, Epidemiology and Market Forecast – 2025
DelveInsight’s “Varicose Veins - Market Insights, Epidemiology and Market Forecast – 2025” Reports p...
10 Jul 2017 by Delve Insight USD $5,750 More Info
Varicose Veins - Epidemiology Insights to 2025
DelveInsight “ Varicose Veins - Epidemiology Forecast To 2025” provides an overview of the epidemiol...
10 Jul 2017 by Delve Insight USD $2,950 More Info
Varicose Veins - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s, Varicose Veins - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2...
01 Jul 2017 by Delve Insight USD $1,500 More Info
Varicose Veins - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s, Varicose Veins - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2...
01 Jul 2017 by Delve Insight USD $1,500 More Info
Varicose Veins-Pipeline Insights, 2017
DelveInsight’s, “ Varicose Veins-Pipeline Insights, 2017”, report provides in depth insights on the ...
30 May 2017 by Delve Insight USD $1,250 More Info
Global Varicose Vein Treatment Device Market Research Report Forecast 2017 to 2021
The Global Varicose Vein Treatment Device Market Research Report Forecast 2017-2021 is a valuable so...
03 May 2017 by S&P Consulting USD $2,800 More Info
Varicose Vein Treatment Market: By Product (Radiofrequency Ablation Devices, Laser Ablation Devices and Surgical Products); By Treatment (Sclerotherapy, Endovenous Laser Ablation, Stripping, Ambulatory Phlebectomy, Radiofrequency Ablation) & Geography -Forecast (2017-2021)
Varicose Veins also referred to as varicosities are swollen, blue, twisted veins that appear on the ...
26 Apr 2017 by USD $5,250 More Info
Varicose Vein Treatment Market: Endovenous Laser Systems Segment to Dominate the Global Market Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016-2026
User-friendly devices with a greater focus on safety and efficiency will dominate the global marketM...
12 Apr 2017 by Future Market Insights USD $5,000 More Info
Endovenous Laser Therapy Market: Increasing Adoption of Endovenous Laser Therapy for Varicose Veins Treatment Likely to Fuel Market Revenue Growth: Global Industry Analysis and Opportunity Assessment 2016-2026
Endovenous laser systems segment is expected to register high CAGR during the forecast periodEndoven...
21 Feb 2017 by Future Market Insights USD $5,000 More Info
Varicose Veins Global Clinical Trials Review, H2, 2016
Varicose Veins Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Va...
27 Dec 2016 by Global Data USD $2,500 More Info

This report is published by Black Swan Analysis

Black Swan Analysis, founded in 2007, is a unique analysis practice that provides robust valuations and commercialisation plans to optimise products in the healthcare industry. We know what it takes to succeed in this industry -we’ve seen what works and what doesn’t and we are committed to bringing insight and high quality solutions to our clients. In doing so we help them meet the many challenges of today’s complex healthcare marketplace.

The Black Swan team has a unique skill set: the ability to develop dynamic market forecasts and interactive patient flow models using a wide range of data including complex pathological and epidemiological information. As pharmaceutical and healthcare companies are challenged to deliver more specific targets that align with unmet medical needs. These modelling approaches are more commercially focused to meet the requirements of a changing healthcare environment.

We have the capability to provide an immediate and ‘hands-on’ approach with every client and where the right internal expertise is leveraged we can help find your optimal solution. Using our bespoke methodologies and frameworks we seek to assess the most challenging valuations.

The valuation outputs we generate can be easily integrated with any in-house existing financial systems, presentation styles or platforms that may be currently operational. This ensures a faster uptake within the business, enabling resources to be re-directed towards implementing the outputs and leveraging new information.

Our philosophy at Black Swan is to create the right environment using inclusive dialogues and collaboration that enable us to generate outputs that make business decisions clear. Our goal is to provide an unparalleled level of satisfaction and quality for our clients.

Download Free Report Summary PDF

Varicose Veins Forecast in 15 Major Markets 2015-2025 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...